We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ gene introduced into the brains of mice. Injection of these non-replicating vectors into the brain induced systemic antibody production to adenovirus vectors in dose dependent manner. Apparent antibody production to beta-galactosidase, the product of the lacZ gene, was detected later than anti-adenovirus antibody. Neutralizing antibody was not detected. This study demonstrates that E1-deleted adenovirus vectors injected into the brain trigger humoral immune responses to the adenovirus and its gene products, but they are not sufficient to block the infection of cells by adenovirus upon repeat injection
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Human adenovirus type 5 can be used as a vector to elicit immune responses to antigens expressed fro...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
We have investigated the immune response to E1-deleted adenovirus vectors encoding the lacZ gene int...
E1-deleted adenoviral vectors expressing the bacterial beta-galactosidase gene were inoculated into ...
In many organs, E1-deleted human adenovirus vectors trigger antiviral T cell responses which limit t...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Non-replicating adenovirus vectors are being developed as vehicles for gene transfer into cells of t...
A major disadvantage of first generation adenoviral vectors for gene therapy in the brain is the imm...
We report that injecting an E1-deleted, non-replicating, human adenovirus type 5 vector into the bra...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
AbstractTo determine whether non-human adenovirus-specific antibodies are cross-neutralizing, rabbit...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Human adenovirus type 5 can be used as a vector to elicit immune responses to antigens expressed fro...
We have investigated the humoral immune response to E1-deleted adenovirus vectors encoding the lacZ ...
We have investigated the immune response to E1-deleted adenovirus vectors encoding the lacZ gene int...
E1-deleted adenoviral vectors expressing the bacterial beta-galactosidase gene were inoculated into ...
In many organs, E1-deleted human adenovirus vectors trigger antiviral T cell responses which limit t...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Nonreplicating adenovirus vectors are being developed as vehicles for the delivery of therapeutic ge...
Non-replicating adenovirus vectors are being developed as vehicles for gene transfer into cells of t...
A major disadvantage of first generation adenoviral vectors for gene therapy in the brain is the imm...
We report that injecting an E1-deleted, non-replicating, human adenovirus type 5 vector into the bra...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
AbstractTo determine whether non-human adenovirus-specific antibodies are cross-neutralizing, rabbit...
The central nervous system (CNS) is a site of relative immunological privilege; despite this it can ...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Inflammation and immune reaction, or pre-existing immunity towards commonly used viral vectors for g...
Human adenovirus type 5 can be used as a vector to elicit immune responses to antigens expressed fro...